CBE DPHIL - Exscientia CEO Founder

EXAIDelisted Stock  USD 4.84  0.15  3.20%   

CEO

CBE DPHIL is CEO Founder of Exscientia Ltd ADR
Age 51
Phone44 18 6581 8941
Webhttps://www.exscientia.ai

Exscientia Management Efficiency

The company has return on total asset (ROA) of (0.2122) % which means that it has lost $0.2122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4643) %, meaning that it created substantial loss on money invested by shareholders. Exscientia's management efficiency ratios could be used to measure how well Exscientia manages its routine affairs as well as how well it operates its assets and liabilities.
Exscientia Ltd ADR currently holds 18.92 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Exscientia ADR has a current ratio of 8.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Exscientia's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 9 records

CEO Age

Kathryn MBABlueprint Medicines Corp
48
Steven MDSana Biotechnology
54
Markus MDMonte Rosa Therapeutics
53
Frank BeduAddoPDS Biotechnology Corp
59
Mark GoldsmithRevolution Medicines
62
PharmD MBACentury Therapeutics
N/A
Stephen JDPieris Pharmaceuticals
48
Denise ScotsKnightMereo BioPharma Group
65
Adrian RawcliffeAdaptimmune Therapeutics Plc
52
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom. Exscientia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 285 people. Exscientia Ltd ADR (EXAI) is traded on NASDAQ Exchange in USA. It is located in The SchrOedinger Building, Oxford, United Kingdom, OX4 4GE and employs 483 people. Exscientia is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Exscientia ADR Leadership Team

Elected by the shareholders, the Exscientia's board of directors comprises two types of representatives: Exscientia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Exscientia. The board's role is to monitor Exscientia's management team and ensure that shareholders' interests are well served. Exscientia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Exscientia's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Overington, Chief Officer
Eileen JenningsBrown, Chief Officer
Ben AshwellFryer, VP Fin
Parker Moss, Executive Development
Ben Taylor, Chief CFO
CBE DPHIL, CEO Founder
Nikolaus Krall, Executive Medicine
Dan Ireland, Executive Secretary
Heather Togwell, Operations Mang
Caroline Rowland, Chief Officer
Chris Thomas, VP People
Garry Pairaudeau, Chief Officer
MarieLouise MD, Interim Lead
FRSE DPHIL, CEO Founder
David Hallett, Interim Officer
Michael MD, Chief Officer
Margo Mosley, VP Operations
Richard Law, Chief Officer
Sara Sherman, Vice Relations

Exscientia Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Exscientia a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exscientia Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in Exscientia Stock

If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stocks Directory
Find actively traded stocks across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated